Future of the European Union regulatory network in the context of the uptake of new medicines.
作者信息
Hoebert Joëlle M, Irs Alar, Mantel-Teeuwisse Aukje K, Leufkens Hubert G M
机构信息
Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands.
出版信息
Br J Clin Pharmacol. 2013 Jul;76(1):1-6. doi: 10.1111/j.1365-2125.2012.04476.x.
Abstract
摘要
相似文献
1
Future of the European Union regulatory network in the context of the uptake of new medicines.新药品应用背景下欧盟监管网络的未来。
Br J Clin Pharmacol. 2013 Jul;76(1):1-6. doi: 10.1111/j.1365-2125.2012.04476.x.
2
Perseverance.坚持不懈。
Prescrire Int. 2011 Feb;20(113):54.
3
Pharmaceutical regulation in the single European market.单一欧洲市场的药品监管
Med Law. 1998;17(3):401-27.
4
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children.欧洲儿科制剂倡议组织（EuPFI）第二届会议评论——为儿童研发更优质的药物
Int J Pharm. 2011 Oct 31;419(1-2):235-9. doi: 10.1016/j.ijpharm.2011.06.040. Epub 2011 Jun 29.
5
A future for regulatory science in the European Union: the European Medicines Agency's strategy.欧盟监管科学的未来：欧洲药品管理局的战略。
Nat Rev Drug Discov. 2020 May;19(5):293-294. doi: 10.1038/d41573-020-00032-0.
6
[EURO-Medicines: a European program for bringing into agreement public health policies on drugs].[欧洲药品计划：一项使欧洲各国在药品公共卫生政策上达成一致的计划]
Ann Ig. 1998 Sep-Dec;10(5-6):405-12.
7
Physiologically based pharmacokinetic modeling: from regulatory science to regulatory policy.基于生理学的药代动力学建模：从监管科学到监管政策。
Clin Pharmacol Ther. 2014 May;95(5):478-80. doi: 10.1038/clpt.2014.46.
8
Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.朝着儿科药物监管要求的范式转变迈进。
Eur J Pediatr. 2016 Dec;175(12):1881-1891. doi: 10.1007/s00431-016-2781-z. Epub 2016 Sep 19.
9
[The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].[瑞典医疗产品管理局在欧盟关于儿童与药品的新法规出台前的准备工作]
Lakartidningen. 2007;104(28-29):2099.
10
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.东非共同体药品监管协调倡议八年：实施、进展和经验教训。
PLoS Med. 2020 Aug 12;17(8):e1003134. doi: 10.1371/journal.pmed.1003134. eCollection 2020 Aug.
本文引用的文献
1
International Variation in the Usage of Medicines: A Review of the Literature.药品使用的国际差异：文献综述
Rand Health Q. 2011 Mar 1;1(1):4. eCollection 2011 Spring.
2
Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective.欧洲新肿瘤产品的市场与患者可及性：当前的多学科视角
Ann Oncol. 2009 Mar;20(3):403-12. doi: 10.1093/annonc/mdn603. Epub 2008 Oct 14.
3
Patient access to pharmaceuticals: an international comparison.患者获取药品情况：一项国际比较
Eur J Health Econ. 2007 Sep;8(3):253-66. doi: 10.1007/s10198-006-0028-z. Epub 2007 Feb 6.
Zotero 插件